Criteria for Driver's License Suspension in Severe Obstructive Sleep Apnea

Primary Criteria for License Suspension

The American Academy of Sleep Medicine recommends that a driver's license should be immediately suspended in patients with severe OSA who report excessive daytime sleepiness during driving, have experienced a drowsiness-related accident, or have fallen asleep while driving, until effective therapy is established and documented 1, 2, 3
A patient should be considered for immediate license suspension if they have experienced an accident associated with drowsiness, as this indicates a high risk of future accidents 2, 3
The American Academy of Sleep Medicine suggests that patients with severe OSA (AHI ≥ 20 events/h) and noncompliance with treatment recommendations should have their driver's license suspended immediately 2, 4

Direct questioning about daytime sleepiness is essential, specifically asking about falling asleep unintentionally during daily activities, as recommended by the American Journal of Respiratory and Critical Care Medicine 3, 5
Inquiring about recent motor vehicle crashes or near-misses attributable to sleepiness, fatigue, or inattention is crucial in assessing high-risk drivers 3, 6
Assessing for additional factors that may increase driving risk, such as sleep restriction, alcohol use, sedating medications, and comorbid neurocognitive impairments, is necessary for a comprehensive evaluation 4, 5, 6

The American Academy of Sleep Medicine defines minimally acceptable adherence to PAP therapy as ≥4 hours per day of use on ≥70% of days, which is essential for treatment efficacy 1, 4
Treatment effectiveness must be demonstrated through review of PAP device data, resolution of symptoms, and improvement in physical examination findings, such as blood pressure 2, 4
Patients should be advised that optimal benefits of PAP therapy occur with 7+ hours of daily use, as recommended by the American Academy of Sleep Medicine 4, 7

Patients with mild-to-moderate OSA (AHI <20 events/h) without excessive daytime sleepiness may continue driving without restrictions, according to the American Academy of Sleep Medicine 7, 9
The apnea-hypopnea index alone should not determine driving risk, and clinical assessment of sleepiness is essential, as stated by the American Journal of Respiratory and Critical Care Medicine 6
Oral appliance therapy may be considered for patients with mild-to-moderate OSA (AHI 5-20 events/h), but a sleep study showing efficacy is required before allowing return to driving, as recommended by the American Academy of Sleep Medicine 1, 8